Acute effect of combining weight and elastic resistance on vascular function in Thailand

Phase 1

• Registration Number: TCTR20220623001
• Lead Sponsor: Research and Development Institute, Phuket Rajabhat University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2022-06-23
• Study Completion: 2022-07-14
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Pending (Not yet recruiting)
• Sex: All
• Target Recruitment: 14

Inclusion Criteria

1. All healthy elderly participants (aged between 60-70 years) live in Phuket, 2. All participants are screened by Physical Activity Readiness Questionnaire (PAR-Q), 3. If participants answer no to all questions in PAR-Q, they are cleared for physical activity participation, 4. None of the participants receive outpatient care for any reason, 5. None of the participants have experienced any cardiovascular, cerebrovascular or neuromuscular disease, 6. None of the participants have vision problems, hearing, and vestibular functioning problems, 7. None of the participants take tranquilizer and antidepressants that affect balance, 8. None have any exercise habits including aerobic exercise, endurance training, resistance training, et cetera, for at least 6 months before the beginning of the study, 9. All participants are non-smoker and without any supplement, 10. All participants receive information sheet for research participant and sign the inform consent.

Exclusion Criteria

1. The participants feel pain in the upper or lower extremities in activities of daily living, 2. The participants have received antihypertensive, hypolipidemic or hypoglycemic medications, 3. The participants show systolic blood pressure (SBP) of more than 140 mmHg, and diastolic blood pressure (DBP) of more than 90 mmHg, 4. The participants perform a Senior Fitness Test (SFT), and those who obtain a score of less than 25th percentile of age-based norms before testing are excluded from the study.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Flow-mediated dilation (FMD) at 1 months after end of the intervention Flow-mediated dilation is evaluated with the ultrasound equipment.

Secondary Outcome Measures

Name	Time	Method
pulse wave velocity (PWV) at 1 months after end of the intervention pulse wave velocity is measured using a volume-plethysmographic device with four cuffs matched with oscillometric sensors